Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to RIMS3 (ENSG00000287743)
- Target
- ENSG00000287743
- Molecular classification
- Non-coding RNA, Natural antisense transcript (NAT), Other
01
Overview
"Novel transcript, antisense to RIMS3" (ENSG00000287743) refers to a non-coding RNA molecule transcribed in the antisense direction relative to the RIMS3 gene. It falls within the class of natural antisense transcripts (NATs), which regulate gene expression at the transcriptional or post-transcriptional level by mechanisms such as RNA masking, transcriptional interference, or facilitating epigenetic silencing[2][3][4]. Antisense transcripts are common in the human genome and have general roles in modulating gene activity, but specific biological functions, disease associations, or druggability have not been described for this particular molecule. No evidence supports its use as a therapeutic target, biomarker, or drug receptor at this time[4].
- Other names
- Antisense to RIMS3ENSG00000287743
02
Biological functions
Regulation of gene expression in cis (local effect on RIMS3 expression)Possible involvement in epigenetic silencing or transcriptional interferenceOther (potential RNA masking, but unconfirmed for this specific transcript)
Beyond the preview
Go deeper on Novel transcript, antisense to RIMS3 (ENSG00000287743).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to RIMS3 (ENSG00000287743).